Chemotherapy
What are the latest developments in chemotherapy for pancreatic cancer patients? Read about targeting treatments and other options under study.
28 Articles
![RNA](https://letswinpc.org/wp-content/uploads/2024/07/RNA-with-background.png)
Testing a New Chemo and RNA Therapy Combination
Researchers are testing a new drug that binds to messenger RNA in combination with mFOLFIRINOX chemotherapy.
![light microscope in a lab](https://letswinpc.org/wp-content/uploads/2024/06/Light_Microscope.jpg)
Pancreatic Cancer Research Updates from ASCO 2024
Learn about the latest developments in pancreatic cancer research into immunotherapy and chemotherapy from the ASCO 2024 meeting.
![Dr. Allyson Ocean](https://letswinpc.org/wp-content/uploads/2022/10/Allyson_Ocean.jpg)
Leveraging Nanoparticle Technology for Paclitaxel Delivery in Pancreatic Cancer Patients
Dr. Allyson Ocean explains why nanoparticle delivery technology for getting paclitaxel to the tumor could be advantageous for patients.
![Lets Win PC logo](https://letswinpc.org/wp-content/uploads/2022/11/LetsWinPC-logo-720x480-2.gif)
ASCO GI Symposium Features a Broad Range of Pancreatic Cancer Research
Researchers at ASCO GI 2024 reported on research in health disparities, KRAS and other genetic mutations, and novel treatments.
![Aqua gloved hands holding lab equipment](https://letswinpc.org/wp-content/uploads/2023/12/Customs-lab.jpg)
Progress and Promise—Research in 2023
What advances were made in 2023 for pancreatic cancer treatments? Where is research headed in the coming year?
![Dr. Anup Kasi](https://letswinpc.org/wp-content/uploads/2021/12/Anup-Kasi-v4.jpg)
Potential Therapy Takes a Two-Prong Attack on Pancreatic Cancer
With a focus on targeting cell metabolism, Dr. Anup Kasi leads a clinical trial of a new agent in combination with gemcitabine.
![AACR, Let's Win, Lustgarten logos](https://letswinpc.org/wp-content/uploads/2023/04/aacr-lw-lustgarten.png)
Pancreatic Cancer Research Builds Upon Strengths
The September 2023 AACR Special Conference on Pancreatic Cancer focused on the latest research in KRAS, chemotherapy, and cachexia, among other topics.
![Dr. Jordan Winter. right](https://letswinpc.org/wp-content/uploads/2023/09/Jordan-Winter-new.jpg)
Higher Glucose Levels May Improve Chemotherapy Effectiveness
Can higher glucose levels make chemotherapy more effective? Dr. Jordan Winter and colleagues are studying the relationship.
![Slide of pancreatic cancer](https://letswinpc.org/wp-content/uploads/2023/08/Adenocarcinoma_of_Pancreas_FNA.jpg)
Targeting Pancreatic Cancer Cell Growth
Researchers are testing a new drug targeting cell growth in solid tumors, including pancreatic cancer.
![Lets Win PC logo](https://letswinpc.org/wp-content/uploads/2022/11/LetsWinPC-logo-720x480-2.gif)
ASCO 2023: Pancreatic Cancer Research Update
The pancreatic cancer research reports from ASCO 2023 focused on different chemotherapy combinations, including immunotherapy.
![yellow orange lines against a black background](https://letswinpc.org/wp-content/uploads/2023/05/piezoresponse.jpg)
Adapting Chemotherapy Regimens for a Better Pancreatic Cancer Outcome
Researchers are comparing chemotherapy regimens for effectiveness before surgery, and whether switching treatments makes a difference.
![Dr. Marco Del Chiaro, pancreatic cancer surgeon](https://letswinpc.org/wp-content/uploads/2023/05/Del_Chiaro_Marco-horiz.jpg)
New Study Shows Benefit of Chemotherapy after Surgery
Should you have adjuvant chemotherapy–treatment after pancreatic cancer surgery? Dr. Marco Del Chiaro explains that the evidence says “yes.”
![altered photo of bottles in teal and aqua](https://letswinpc.org/wp-content/uploads/2023/05/snap-cap-bottles.jpg)
Chemo and SBRT for Inoperable Pancreatic Cancer
For inoperable pancreatic cancer, researchers are comparing mFOLFIRINOX and SBRT with gemcitabine-based treatment regimens.
![molecule model made of silvery beads on a yellowish background](https://letswinpc.org/wp-content/uploads/2023/03/beaded-molecule.jpg)
Comparing Chemotherapy Before with Chemotherapy After Pancreatic Cancer Surgery
Researchers are comparing effectiveness of chemotherapy before surgery (neoadjuvant) with chemotherapy after surgery (adjuvant).